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Epidemiologic studies have shown that
exposure to PM10 (particulate matter ≤ 10 µm
in diameter) is associated with decreased lung
function and increased emergency hospital
admissions for respiratory diseases (Atkinson
et al. 1999; Dusseldorp et al. 1995). Exposure
to PM2.5 (PM ≤ 2.5 µm in diameter) is related
to increases in all-cause, cardiopulmonary, and
lung cancer mortality (Laden et al. 2000; Pope
et al. 2002). In ambient air, carbon-centered
ultraﬁne particles (PM ≤ 0.1 µm in diameter)
are often generated during internal combustion
processes and constitute most fine or coarse
particulate matter (Oberdorster and Utell
2002). In adults with a history of asthma, ultra-
ﬁne particles play a more signiﬁcant role in pro-
ducing detrimental respiratory effects than does
PM10 (Peters et al. 1997). Use of asthma med-
ication is associated with an increase in the
number concentration of ultrafine particles
(Von Klot et al. 2002). These ﬁndings indicate
that exposure to ultraﬁne particles can increase
the susceptibility of individuals with preexisting
diseases to particle health effects.
Our knowledge of ultrafine-particle–
induced lung injury has drawn on in vivo stud-
ies of ultraﬁne materials, such as ultraﬁne tita-
nium dioxide (ufTiO2; 20 nm in diameter)
and ultrafine carbon black (ufCB; 14 nm in
diameter). ufTiO2 particles provoke inﬂuxes of
polymorphonuclear cells, enhance protein
exudation into alveolar space, prolong particle
interstitial retention, and increase lung lymph
node burden to a greater extent than do ﬁne
TiO2 particles (~ 250 nm in diameter) in rats
(Ferin et al. 1992; Oberdorster et al. 1992).
Significantly greater increases in neutrophil
influx and total protein in bronchoalveolar
lavage (BAL) ﬂuid are observed after intratra-
cheal instillation of ufCB, compared with car-
bon black (CB; 250 nm in diameter) (Li et al.
1996). This may be due to the relatively large
particle number and surface area per unit of
deposited ufCB mass (Donaldson et al. 1998;
Oberdorster 1996; Stone et al. 1998). A recent
study has found that the time response of the
increase in total proteins after ufCB instillation
is very similar to that of neutrophil inﬂux and
that significant increases in tumor necrosis
factor-α (TNF-α) production and total pro-
teins are present 6 hr after instillation of ufCB
(Li et al. 1999). However, another study has
found that ufCB induces a signiﬁcant inﬂux of
neutrophils but only a moderate and non-
signiﬁcant increase in total proteins (Dick et al.
2003). These studies do not elaborate on the
attributes that may contribute to the increase
of alveolar-capillary permeability. As a result,
the mechanism of ufCB-induced alveolar-
capillary permeability has yet to be elucidated.
Vascular endothelial growth factor (VEGF)
is an endothelial-cell–speciﬁc mitogen and the
most potent vascular growth factor found
to date. It induces vasculogenesis from pre-
endothelial cells and angiogenesis from pre-
existing capillaries (Carmeliet 2000; Ferrara
1999). In addition, VEGF had been identiﬁed
as a vascular permeability factor before its dis-
covery as an endothelial cell mitogen (Senger
et al. 1983, 1993). By delivering E1– adeno-
virus vector (AdVEGF165) to the mouse respi-
ratory epithelium, the overexpression of
VEGF165 isoform significantly increased
pulmonary vascular permeability 24 hr after
administration (Kaner et al. 2000). In mice,
time-dependent increases of total lung VEGF
mRNA are associated with neutrophil inﬂux
and increases in total proteins in BAL fluid
after exposure to lipopolysaccharide (LPS)
(Karmpaliotis et al. 2002).
Reactive oxygen species (ROSs) have been
shown to stimulate VEGF production (Chua
et al. 1998; Kuroki et al. 1996). ufCB is capa-
ble of depleting supercoiled plasmid DNA and
increasing 2´,7´-dichlorofluorescein (DCF)
fluorescence in a cell-free system, indicating
the existence of surface free radical activity
(Dick et al. 2003; Stone et al. 1998; Wilson
et al. 2002). After incubation with human
monocytes, ufCB can further stimulate the
production of ROS and increase oxidative
stress (Wilson et al. 2002). As a result, it is rea-
sonable to hypothesize that ufCB can cause
oxidative stress and increase the production of
VEGF in lung tissue.
The purpose of this study is to investigate
the role of VEGF in ufCB-induced lung injury.
Accordingly, the study explores the kinetic of
VEGF production and its inﬂuence on alveolar-
capillary permeability after exposure to ufCB.
In addition, the involvement of ROSs in ufCB-
induced production of VEGF is investigated.
Materials and Methods
Animals. Male ICR mice were purchased
from the animal center at National Cheng
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Ultraﬁne carbon black (ufCB) can cause proinﬂammatory response and increase alveolar-capillary
permeability. However, the mechanism underlying the increased permeability is not well charac-
terized. Vascular endothelial growth factor (VEGF) is originally recognized as a vascular perme-
ability factor. Oxidative stress generated by hydrogen peroxide (H2O2) stimulates VEGF gene
expression. The purpose of this study was to explore the role of VEGF in ufCB-induced alveolar-
capillary permeability. Intratracheal instillation of 200 µg ufCB in mice caused a signiﬁcant and
sustained increase of total proteins in bronchoalveolar lavage (BAL) fluid, with the maximal
increase at 21 hr postinstillation. The influx of neutrophils did not significantly increase until
16 hr. It reached the highest level at 21 hr and returned to the basal level by 42 hr. Tumor necro-
sis factor-α was signiﬁcantly elevated only at 4 hr. ufCB induced signiﬁcant increases of VEGF in
BAL ﬂuid throughout the study period, with the peak increase at 16 hr. The nonsecreted isoform
VEGF188 was not altered after 16 hr of exposure to ufCB. Moreover, there was a strong correla-
tion between VEGF and total proteins in BAL ﬂuid (R2 = 0.7352, p < 0.01). In vivo study sup-
ported the role of reactive oxygen species (ROSs) in ufCB-induced VEGF release and protein
leakage. The involvement of ROSs was strengthened by the fact that interventions with N-acetyl-
cysteine prevented ufCB-induced generation of ROSs and VEGF in vitro. Our study for the ﬁrst
time demonstrates that ufCB induces the production of VEGF, which is associated with the
increase of alveolar-capillary permeability. The induction of VEGF by ufCB acts through an ROS-
dependent pathway. Key words: intratracheal instillation, permeability, reactive oxygen species,
ultrafine carbon black, vascular endothelial growth factor, VEGF. Environ Health Perspect
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experiments were conducted according to the
National Institutes of Health (NIH) guidelines
(NIH 1996). The procedures were approved
by the Animal Care and Use Committee of
Kaohsiung Medical University.
Particle preparation. ufCB (Printex 90;
diameter, 14 nm; surface area, 253.9 m2/g;
Degussa, Frankfurt, Germany) was weighed,
ground, and suspended in phosphate-buffered
saline (PBS; pH 7.4). The suspension was
then sonicated (model W-250; Branson,
Danbury, CT, USA) for 20 min (20 W)
before adjusting it to the ﬁnal concentration of
2 µg/µL.
Intratracheal instillation and broncho-
alveolar lavage. Male ICR mice were housed
two per cage in the Kaohsiung Medical
University animal center with a schedule of
14 hr of light (0500–1900 hr) and with room
temperature control (24 ± 1°C). At the age of
5 weeks and weight 25–30 g, the mice were
anesthetized by intraperitoneal injection with
1.25% citosol (Kyorin Pharmaceuticals,
Tokyo, Japan) and instilled with an intratra-
cheal application with 100 µL ufCB (200
µg/100 µL/mouse) or LPS (1 µg/µL, 100
µg/100 µL/mouse; Sigma, St. Louis, MO,
USA). Sterile PBS (100 µL) was used as our
vehicle control. At 4, 16, 21, and 42 hr after
intratracheal instillation, the mice were eutha-
nized by intraperitoneal injection with 2.5%
citosol. The lung was exposed and the trachea
was cannulated for lavaging the broncho-
alveolar space two times with 1 mL PBS. The
BAL samples were centrifuged at 300 × g for
10 min. The cell pellets were resuspended in
1 mL RPMI 1640 medium. The primary
lavage recovered was separated from subse-
quent lavage and used for the measurement of
total proteins, TNF-α, and VEGF in BAL
fluid. For Western blotting analysis, the
unlavaged lungs were removed, minced into
small pieces, snap-frozen in liquid nitrogen,
and stored at –80°C until analyzed for VEGF.
Initially, there were eight mice for each
time point (except n = 4; n = 3 for 42-hr expo-
sure group). To conclude that the peak
increase of VEGF appeared before that of total
proteins, a second study was conducted with a
total of eight mice for the 16-hr exposure
group (n = 4) and 10 mice for the 21-hr expo-
sure group (n = 5). In total, for the 4-hr group,
n = 4; 16-hr group, n = 8; 21-hr group, n = 9;
42-hr group, n = 3.
To further study the effects of N-acetyl-
cysteine (NAC; a glutathione precursor and
antioxidant) on ufCB-induced productions of
VEGF and total proteins, mice were injected
with NAC (320 mg/kg) intraperitoneally 2 hr
before ufCB instillation. Mice were sacriﬁced
after 16 hr of exposure to ufCB.
Analysis of BAL leukocytes. An aliquot of
the cell suspension was examined for total
number of white blood cells using a hemo-
cytometer (Paul Marienfeld GmbH, Lauda-
Koenigshofen, Germany). In addition, cytospin
slides were prepared using 3 × 104 cells cen-
trifuged at 180 × g for 5 min onto glass slides.
After Liu stain, differential cell counts of neu-
trophils, macrophages, and lymphocytes were
determined by counting 400 cells under a
microscope (magnification, 400×; Olympus,
Tokyo, Japan).
Quantitation of total proteins, VEGF, and
TNF-α in BAL ﬂuid. Total proteins in BAL
ﬂuid were measured using a Bio-Rad protein
assay kit, according to the manufacturer’s man-
ual (Bio-Rad, Hercules, CA, USA). Enzyme-
linked immunosorbent assays (ELISAs) were
adopted to measure mouse VEGF and TNF-α
and performed according to manufacturer’s
protocols (R&D systems, Chantilly, VA,
USA). VEGF ELISA detects mature VEGF
containing 120 and 164 amino acid residues
(secreted VEGF). The optical density of each
sample was determined at a wavelength of
450 nm and a reference wavelength of 540 nm
by a microplate reader (OpsysMR, DYNEX,
Minneapolis, MN, USA).
Western blot analysis. Lung tissues were
grounded in lysis buffer containing 20 mM
Tris, 150 mM NaCl, 1 mM EDTA, 1%
Nonidet P-40, 1 mM Na3VO4, and 100
µg/mL phenylmethylsulfonyl fluoride. After
being centrifuged (Microfuge R, Beckman, CA,
USA) at 7,500 × g, 4°C for 20 min, the super-
natant was collected for measuring protein con-
tents using a Bio-Rad protein assay kit. Bovine
serum albumin (BSA) was used as the standard.
Equal amounts of tissue homogenate (100 µg)
were loaded to each lane on a 12.5% sodium
dodecyl sulfate–polyacrylamide gel. Molecular
weight markers of proteins were loaded simulta-
neously. After electrophoresis at 4°C for 6 hr,
separated proteins in the gel were transferred
onto a polyvinyldifluoride membrane. The
membrane containing transferred proteins was
treated with 5% nonfat milk in PBS Tween to
block nonspecific binding. After incubations
with ﬁrst and secondary antibodies, the mem-
brane was treated with electrogenerated chemi-
luminescence reagents to enhance signals.
Finally, exposure of the membrane to the light-
imaging ﬁlm (Kodak, Boston, MA, USA) visu-
alized the bands. The protein abundance of
β-actin was detected as an internal control.
Densitometry with a computerized image ana-
lyzer was used to quantify the results (GelDoc-
IT System; UVP, Upland, CA, USA).
Two primary antibodies were used in
this study: VEGF (1:1,500; Santa Cruz
Biotechnology, Santa Cruz, CA, USA) and
β-actin (1:10,000; Chemicon, Temecula, CA,
USA). VEGF antibody can react with all three
VEGF isoforms in mice.
Histochemistry. Shortly after the mice were
sacriﬁced, the lungs were ﬁxed by instillation of
10% formaldehyde at a pressure of 25 cm
H2O for 5 min. The specimens were then
merged in 4% paraformaldehyde at 4°C
for 48 hr. After fixation and washing, the
specimens were embedded in paraffin wax.
Sections 5 µm thick from each parafﬁn block
were expanded on slides and stained with
hematoxylin and eosin (H&E; Vector Labs,
Burlingame, CA, USA). The histopathologic
analysis was performed using a microscope
with cooled charged couple device (magniﬁca-
tion, 1,000×; Olympus).
Measurement of ufCB-induced ROS pro-
duction in THP-1 and A549 cells by DCFH-
DA. ROS production was determined using
2´,7´-dichlorofluorescein diacetate (DCFH-
DA), which was an oxidant-sensitive ﬂuores-
cent probe. Inside the cell, the probe was
deacetylated by esterases and formed H2DCF,
which was oxidized by ROS to DCF, a highly
ﬂuorescent compound (LeBel et al. 1992).
THP-1, a human monocyte cell line,
was obtained from American Type Culture
Collection (Manassas, VA, USA) and cultured
in RPMI 1640 medium supplemented with
10% fetal bovine serum (FBS), 1% penicillin/
streptomycin, and 1% L-glutamine in a 37°C
humidiﬁed incubator supplied with 5% CO2.
Before treatment, cells (7 × 105) were loaded
with 20 µM (ﬁnal concentration) DCFH-DA
for 1 hr. The cells were then treated for 4 hr
with 100 µg/mL ufCB or culture medium,
with or without 20 mM NAC pretreatment for
1 hr. Cell viability was checked using trypan
blue exclusion test and was > 95% in all
groups. The DCF fluorescence intensity was
determined by a FLUOStar OPTIMA (BMG
LabTech, Offenburg, Germany). The arbitrary
value of emitted DCF fluorescence intensity
would reflect the extent of ROS production
in THP-1 cells.
A549, a human lung adenocarcinoma cell
line/type II alveolar epithelial cell, was obtained
from American Type Culture Collection and
cultured in Dulbecco modiﬁed Eagle medium
supplemented with 10% FBS, 1% penicillin/
streptomycin, and 1% L-glutamine in a 37°C
humidiﬁed incubator supplied with 5% CO2.
Cells (7 × 105) adhering to the culture dish
were treated for 4 hr with 100 µg/mL ufCB
or culture medium, with or without 20 mM
NAC pretreatment for 1 hr. At the end of
incubation periods, cells were washed with
PBS and immediately detached with trypsin/
EDTA, and then incubated for 30 min with
20 µM (final concentration) DCFH-DA at
37°C. The cells were washed twice with PBS,
followed by analysis on a FACSCalibur flow
cytometer (Becton Dickinson Biosciences, San
Jose, CA, USA). The ﬂuorescence was plotted
against the number of cells. The extent of ROS
production in A549 cells was indicated as the
ratio of mean ﬂuorescence intensity of treated
cells to PBS control.
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Quantitation of ufCB-induced VEGF
production in THP-1 and A549 cells. THP-1
and A549 cells (7 × 105) were treated for 4 hr
with 100 µg/mL ufCB in serum-free culture
media, with or without 20 mM NAC pre-
treatment for 1 hr. To determine cellular
VEGF production, cultured cells were treated
with lysis buffer containing 1% Nonidet
P-40, 0.5% sodium deoxycholate, 10%
sodium dodecyl sulfate, 1 mM Na3VO4, and
100 µg/mL phenylmethylsulfonyl fluoride.
Cellular VEGF concentrations were assessed
by human VEGF ELISA kit (R&D Systems,
Minneapolis, MN, USA) and normalized to
protein contents.
Data analysis and statistical evaluation. All
data are expressed as means ± SE. Comparisons
between groups were performed using one-way
analysis of variance followed by a pairwise
comparisons in the means model of SPSS
(SPSS, Chicago, IL, USA). The relationship
between cytokine production and total pro-
teins was evaluated using the coefficient of
determination (R2). In all cases, a p-value of
< 0.05 was considered statistically signiﬁcant.
Results
Time-dependent effect of ufCB-induced acute
lung injury. Total proteins in BAL ﬂuid were
measured as an indicator of alveolar-capillary
permeability, and BAL leukocytes with dif-
ferential counts were calculated as an indicator
of inflammatory cell infiltrated in alveolar
space. In conjunction, the amounts of TNF-α
and VEGF in BAL ﬂuid were measured. Our
preliminary data had indicated that ufCB at
200 µg/mouse induced the greatest VEGF
production and protein leakage. Accordingly,
we used ufCB at 200 µg/mouse in this study.
When compared with the controls, ufCB
induced signiﬁcant increases of total proteins
in BAL ﬂuid at 4, 16, 21, and 42 hr postinstil-
lation (Figure 1A). Total proteins reached the
maximal level at 21 hr and were still evident
42 hr later. However, ufCB induced a slower
influx of BAL neutrophils, which became
moderate but significant increase at 16 hr,
maximal increase at 21 hr, and no measurable
difference from the control group by 42 hr
(Figure 1B). The data indicated that the
increase of alveolar-capillary permeability
started earlier than the increase in neutrophil
influx. Moreover, the increased alveolar-
capillary permeability sustained for a longer
period than did neutrophil inﬂux.
Correspondingly, the time-dependent
effects of ufCB on the production of TNF-α
and VEGF in BAL ﬂuid were determined. Four
hours after instillation of ufCB, there was a
significant increase of TNF-α in BAL fluid,
compared with control group (p < 0.05).
However, the marked increase of TNF-α at
4 hr decreased to a level with no difference
from that of control group at 16 hr, and it
further dropped at 21 hr and 42 hr (Figure 2A).
As for VEGF, there were three VEGF isoforms
(VEGF188, VEGF164, and VEGF120) with
different molecular weights in mouse lung tissue
(Shima et al. 1996). VEGF188 containing
heparin-binding domain was considered a non-
secreted form of VEGF. Western blotting was
adopted to evaluate the changes of nonsecreted
VEGF188. VEGF164 and -120, having no
heparin-binding domain, were secreted forms
and could be measured by ELISA. Western blot
analysis showed that the expression of non-
secreted VEGF188 was not signiﬁcantly differ-
ent from that of control (Figure 2B). The data
from ELISA indicated that the secreted forms of
VEGF in BAL ﬂuid were signiﬁcantly increased
at 4, 16, 21, and 42 hr postinstillation. Most
signiﬁcantly, VEGF reached the highest level at
16 hr postinstillation (Figure 2C). These sug-
gested that ufCB increased the production of
TNF-α and secreted forms of VEGF in a time-
dependent manner.
Taken together, there was a significant
elevation of TNF-α, VEGF, and total pro-
teins in BAL fluid at 4 hr postinstillation to
ufCB. VEGF reached the maximal increase
at 16 hr postinstillation (Figure 2C), which
was earlier than that of total proteins at 21 hr
(Figure 1A).
BAL cytology and histopathology. Figure 3
presents illustrations of cytospins and histo-
pathologic pictures from mice after 16 hr of
exposure to PBS, ufCB (200 µg/mouse), or LPS
(100 µg/mouse). Macrophages appeared as giant
cells with nonsegmented nuclei. Neutrophils
had segmented nuclei and were smaller than
macrophages. In ufCB and LPS treatment
groups, most inflammatory cells were neu-
trophils (Figure 3B,C). ufCB aggregates could
be seen in macrophages (Figure 3B,E).
Histopathologic study revealed thickened
alveolar walls in the lungs of mice that received
ufCB treatment (Figure 3E). There were less
obvious changes in mice challenged with LPS
(Figure 3F). The alveolar wall remained intact
in PBS treatment group (Figure 3D).
Cytokine production and alveolar-capillary
permeability. Compared with PBS control,
ufCB caused a signiﬁcant increase in protein
contents at 16 hr postinstillation, as did the
LPS treatment group (p < 0.01) (Figure 4A).
ufCB and LPS both triggered significant
increases in VEGF productions, compared with
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Figure 2. Time-dependent effect of ufCB (200 µg/mouse) on production of (A) TNF-α and (C) VEGF. The value of each point is expressed as a mean ± SE of three to
nine mice. (B) Western blot analysis. The protein abundance of VEGF188 isoform in lung tissue is not altered after 16 hr of exposure to ufCB.
*p < 0.01 and #p < 0.05 compared with the control at that time point. PBS control (p < 0.01) (Figure 4B). In contrast
to the significant increase of TNF-α in LPS
treatment group (p < 0.01), the TNF-α level of
ufCB treatment group was not substantially
different from that of the PBS control group at
16 hr postinstillation (Figure 4B).
To explore the role of VEGF in ufCB-
induced protein leakage, we plotted the total
proteins against the VEGF, using the data
from Figure 4A,B. Analysis showed a co-
efficient of determination (R2) of 0.7352
between VEGF and total proteins (p < 0.01;
Figure 4C). The data strongly suggested
that the secretion of VEGF120 and -164 was
associated with the increase of alveolar-capillary
permeability.
The involvement of ROS in ufCB-
induced production of VEGF in mice. The
effects of interventions with NAC on VEGF
productions and total proteins in mice are
shown in Figure 5A,B. Pretreatment with
NAC (320 mg/kg) 2 hr before ufCB instilla-
tion signiﬁcantly lowered the levels of VEGF
and total proteins, compared with ufCB treat-
ment alone (p < 0.01). These findings sup-
ported the role of ROSs in ufCB-induced
VEGF release and protein leakage.
The involvement of ROS in ufCB-
induced production of VEGF in cultured
cells. To strengthen the hypothesis that oxida-
tive stress played a role in ufCB-induced pro-
duction of VEGF, the effects of NAC on
ROS and VEGF productions were analyzed
in ufCB-treated THP-1 and A549 cells. ufCB
at 100 µg/mL triggered a signiﬁcant increase
of ROSs in THP-1 cells, as measured by
the increase of DCF fluorescence intensity.
Pretreatment with NAC (20 mM) 1 hr before
ufCB exposure significantly reduced ROS
production, compared with ufCB treatment
alone (p < 0.01) (Figure 6A). The addition of
NAC also significantly prevented ufCB-
induced VEGF production in THP-1 cells,
compared with ufCB treatment alone
(p < 0.01) (Figure 6B). Figure 6C shows a rep-
resentative histogram in which the fluores-
cence is plotted against the number of cells.
ufCB at 100 µg/mL caused the oxidative stress
in A549 cells, as indicated by the ratio of
mean fluorescence intensity of ufCB-treated
cells to PBS-treated control cells (ratio = 11.6).
Pretreatment with NAC 1 hr before ufCB
exposure lowered the level of ufCB-induced
oxidative stress, as indicated by the ratio of
mean fluorescence intensity of ufCB plus
NAC-treated cells to PBS-treated cells (ratio =
6.19). The addition of NAC significantly
reduced ufCB-induced VEGF production in
A549 cells, compared with ufCB-treated cells
without antioxidant intervention (p < 0.01)
(Figure 6D). Taken together, exposure to
ufCB caused the oxidative stress, and NAC
prevented ufCB-induced oxidative stress and
production of VEGF in THP-1 and A549
cells. These data indicate that oxidative stress
plays a significant role in ufCB-induced
VEGF production.
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Figure 3. BAL cytology (Liu stain; A–C) and histopathology (H&E stain; D–F) at 16 hr after instillation of ufCB
(200 µg/mouse) or LPS (100 µg/mouse). (A) PBS control; mainly macrophages. (B) ufCB group; mainly
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M, macrophage; N, neutrophil. Bars: A–C, 15 µm; D–F, 5 µm.Discussion
Previous studies of ufCB have focused on its
proinﬂammatory effects, including the inﬂux
of polymorphonuclear cells and the induction
of proinflammatory cytokine TNF-α from
cultured alveolar macrophages (Dick et al.
2003; Donaldson et al. 1998; Li et al. 1999).
Our data in Figure 2A reveal a peak increase
of TNF-α in BAL ﬂuid 4 hr after instillation
of ufCB. TNF-α has been shown to be ele-
vated in the early phase of LPS-induced acute
lung injury. An 8-hr, but not 16-hr, exposure
to heat-killed bacteria induces the maximal
increase of TNF-α in BAL ﬂuid and the peak
increase in epithelial permeability, as meas-
ured by the appearance of instilled I125-BSA
in the blood. Moreover, inhibition of TNF-α
by antibodies against TNF-α can prevent
heat-killed bacteria-induced epithelial perme-
ability (Li et al. 1995). In a murine model of
acute lung injury, significant increases in
TNF-α appear in BAL ﬂuid within 2 hr after
instillation with LPS, but TNF-α levels return
to the basal level by 24 hr postinstallation
(Karmpaliotis et al. 2002). The permeability
effect of TNF-α has been attributed to alter-
ations of the tight junction meshwork in studies
using human epithelial monolayer cells (Gitter
et al. 2000; Schmitz et al. 1999). TNF-α
can also reduce integrin-mediated adhesion
to fibronectin and disrupt lung endothelial
integrity (Rotundo et al. 2002). Therefore, the
increased protein leakage 4 hr after instillation
of ufCB in the present study may be caused
partly by the production of TNF-α.
Because of the large number of particles
and the large surface area per unit mass, a sub-
stantial portion of ultraﬁne TiO2 and ufCB can
easily evade macrophage clearance. This pro-
longs particle retention time, increases interac-
tions between particles and epithelial cells, and
leads to the oxidative stress of epithelial cells
(Donaldson et al. 1998; Ferin et al. 1992). The
increased oxidative stress reduces epithelial cell
integrity. Breaches in the epithelial barrier facili-
tate the transfer of ufCB to the interstitial area
and airway smooth muscle. In situ hybridiza-
tion studies show that VEGF mRNA is mainly
expressed in the alveolar epithelial cells (Bhatt
et al. 2000; Maniscalco et al. 1995). In addi-
tion, airway smooth muscle and macrophages
are other potential sources of VEGF (Cho et al.
2001; Fehrenbach et al. 1999). The prolonged
interactions with a variety of target cells provide
a reasonable explanation as to why a single chal-
lenge of ufCB causes sustained increases of
VEGF in BAL ﬂuid even at 42 hr postinstilla-
tion (Figure 2C).
VEGF activates VEGF receptor-2
(VEGFR-2/Flk-1/KDR) and increases capil-
lary permeability by tyrosine phosphorylation
of the interendothelial adhesion molecule VE-
cadherin (Esser et al. 1998). Through its inter-
action with VEGFR-2 in the endothelial cells,
VEGF also enhances the production of nitric
oxide and prostacyclin and increases vascular
permeability (Murohara et al. 1998). A single
VEGF gene gives rise to three protein isoforms
(VEGF120, VEGF164, and VEGF188)
through alternative mRNA splicing in mice
(Shima et al. 1996). In mouse lung tissues,
RNase protection assay indicates that the
most abundant isoform mRNA is VEGF188
mRNA and the least abundant isoform is
VEGF120 mRNA (Ng et al. 2001). However,
little attention has focused on the protein abun-
dance of different VEGF isoforms in the induc-
tion of alveolar-capillary permeability. Our data
indicate that ufCB causes a sustained increase
of secreted VEGF in BAL ﬂuid (Figure 2C).
The expression of cell-bound, nonsecreted
VEGF188 is not altered in Western blotting
analysis (Figure 2B). As a result, the increased
VEGF120 and VEGF164 isoforms are associ-
ated with the alveolar-capillary permeability.
Normal human lungs express higher
levels of VEGF189 relative to VEGF165 and
VEGF121. In non-small-cell lung carcinoma,
mRNA analysis has shown predominant
expressions of VEGF121 and VEGF165, when
compared with normal lungs (Cheung et al.
1998; Fontanini et al. 1999). The soluble iso-
forms are related to poor prognosis and metas-
tasis (Fontanini et al. 1999; O’Byrne et al.
2000). Different VEGF isoforms have distinct
functions in tumor angiogenesis. In mice, the
most diffusible VEGF120 can recruit vessels
at some distance from the secreting cells.
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Figure 6. Effect of NAC (20 mM, 1-hr pretreatment) on oxidative stress and cellular VEGF production in
cells treated with ufCB (100 µg/mL) for 4 hr. (A) Oxidative stress in THP-1 cells. Data are expressed as
means ± SE of four or ﬁve separate experiments; ufCB group, n = 5. (B) Cellular VEGF in THP-1 cells. (C) A
representative histogram in which the fluorescence (FL-1) is plotted against the number of A549 cells.
Ratios of mean ﬂuorescence intensity of treated cells to PBS control: control (Con), 1; ufCB, 11.6; NAC +
ufCB, 6.19; NAC, 0.71. (D) Cellular VEGF in A549 cells. Data are expressed as means ± SE of four (THP-1) or
three (A549) separate experiments.
*Signiﬁcantly different from the control or between the ufCB + NAC group and the ufCB group (p < 0.01).
Figure 5. Effect of NAC (320 mg/kg, 2 hr before instillation) on (A) VEGF productions and (B) total proteins in
mice after 16 hr of exposure to ufCB (200 µg/mouse). Data are expressed as means ± SE of four mice.
*Signiﬁcantly different from the control or between the ufCB + NAC group and the ufCB group (p < 0.01).
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)The nonsecreted VEGF188 increases the con-
centration locally and works cooperatively
with VEGF120 to expand the capillary bed.
VEGF164 is capable of recruiting vessels with
its partial diffusible property and vascularizing
the tumor with its partial nonsecreted prop-
erty. Therefore, VEGF164 alone can enhance
tumorigenic vascularization and tumor growth
(Grunstein et al. 2000). Further understand-
ing of the regulatory mechanism controlling
differential expression of VEGF isoforms after
exposure to ufCB may have great implications
for our knowledge of the pathogenesis of lung
carcinoma.
As indicated above, results from instillation
studies with ufCB have been controversial
regarding the coincidence of neutrophils inﬂux
and the increase of protein leakage in rats (Dick
et al. 2003; Li et al. 1999). In our study with
mice, the inﬂux of neutrophils is not signiﬁ-
cantly evident until 16 hr after instillation
(Figure 1B). The increase in protein leakage
occurs without the presence of signiﬁcant inﬂux
of neutrophils in the early phase of ufCB-
induced acute lung injury. It is intriguing to
note that ufCB induces a maximal increase of
VEGF at 16 hr, which occurs before the peak
increases of neutrophils inﬂux and protein leak-
age at 21 hr in our study (Figures 1A,B, 2C).
Leukocyte adhesion to endothelial cells is the
step proceeding leukocyte inﬁltration, because
leukocyte adhesion can trigger disorganiza-
tions of endothelial cell adherens and tight
junctions and increases in vascular permeabil-
ity (Del Maschio et al. 1996; Kurose et al.
1994). VEGF can induce the expression of
adhesion molecules that bind leukocytes to
endothelial cells (Detmar et al. 1998; Kim et al.
2001). Furthermore, VEGF has been demon-
strated in activated neutrophils (Gaudry et al.
1997). Neutrophils, via their own VEGF, can
further enhance vascular permeability when
they bind to endothelial cells. Therefore, the
increase in neutrophil adhesion and infiltra-
tion may be another mechanism in the genera-
tion of VEGF-induced vascular permeability.
Studies with deletion mutants of VEGF
promoters have shown that H2O2 increases
macrophage VEGF production through
activation of the VEGF promoter, located
between –449 and –1 (Cho et al. 2001). A
recent report has demonstrated that the oxida-
tive stress incurred by H2O2 increases the
VEGF-A gene expression by increasing the
binding of transcriptional factors Sp1 and Sp3
to proximal GC-rich motif in AGS human
gastric adenocarcinoma cells (Schafer et al.
2003). In our study, the addition of NAC
blocks the ufCB-induced increase of VEGF in
mice (Figure 5A) and prevents the generation
of ROS and VEGF in THP-1 and A549 cells
(Figure 6). These support the involvement of
ROS in ufCB-induced production of VEGF
in lung tissue. Further study is warranted to
investigate the signal transduction pathway
responsible for ufCB-induced VEGF gene
expression in epithelial cells.
In conclusion, the peak increase of VEGF
appears before the maximal increases of neu-
trophils inﬂux and total proteins. Protein leak-
age is highly correlated with VEGF production.
Interventions with NAC can reduce VEGF
productions and protein leakages in ufCB-
treated mice. The involvement of ROS is
strengthened by the fact that NAC prevented
ufCB-induced generations of ROS and VEGF
in THP-1 and A549 cells. This is the first
report to demonstrate the ROS-dependent
induction of VEGF by ufCB and the involve-
ment of VEGF in ufCB-induced lung injury.
With the capability of escaping macrophage
clearance, ufCB has great opportunity to cause
profound effects. Future studies will focus
on the health effects of long-term exposure
to ufCB.
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